{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:22:04Z","timestamp":1791404524003,"version":"4.3.3"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,8,11]],"date-time":"2011-08-11T00:00:00Z","timestamp":1313020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1742-4690-8-65","type":"journal-article","created":{"date-parts":[[2011,8,12]],"date-time":"2011-08-12T06:40:05Z","timestamp":1313131205000},"source":"Crossref","is-referenced-by-count":96,"title":["The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment"],"prefix":"10.1186","volume":"8","author":[{"given":"Bradford K","family":"Berges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R","family":"Rowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,11]]},"reference":[{"key":"2472_CR1","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1126\/science.2971269","volume":"241","author":"JM McCune","year":"1988","unstructured":"McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL: The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science. 1988, 241: 1632-1639. 10.1126\/science.2971269.","journal-title":"Science"},{"key":"2472_CR2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/335256a0","volume":"335","author":"DE Mosier","year":"1988","unstructured":"Mosier DE, Gulizia RJ, Baird SM, Wilson DB: Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature. 1988, 335: 256-259. 10.1038\/335256a0.","journal-title":"Nature"},{"key":"2472_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1006\/smim.1996.0027","volume":"8","author":"BD Jamieson","year":"1996","unstructured":"Jamieson BD, Aldrovandi GM, Zack JA: The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and stem cell gene therapy for AIDS. Sem in Immun. 1996, 8: 215-221. 10.1006\/smim.1996.0027.","journal-title":"Sem in Immun"},{"key":"2472_CR4","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/363732a0","volume":"363","author":"GM Aldrovandi","year":"1993","unstructured":"Aldrovandi GM, Feuer G, Gao L, Jamieson B, Kristeva M, Chen IS, Zack JA: The SCID-hu mouse as a model for HIV-1 infection. Nature. 1993, 363: 732-736. 10.1038\/363732a0.","journal-title":"Nature"},{"key":"2472_CR5","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1126\/science.1990441","volume":"251","author":"DE Mosier","year":"1991","unstructured":"Mosier DE, Gulizia RJ, Baird SM, Wilson DB, Spector DH, Spector SA: Human immunodeficiency virus infection of human-PBL-SCID mice. Science. 1991, 251: 791-794. 10.1126\/science.1990441.","journal-title":"Science"},{"key":"2472_CR6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0065-2776(08)60855-X","volume":"63","author":"DE Mosier","year":"1996","unstructured":"Mosier DE: Human immunodeficiency virus infection of human cells transplanted to severe combined immunodeficient mice. Adv Immun. 1996, 63: 79-125.","journal-title":"Adv Immun"},{"key":"2472_CR7","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/stem.160166","volume":"16","author":"DL Greiner","year":"1998","unstructured":"Greiner DL, Hesselton RA, Shultz LD: SCID mouse models of human stem cell engraftment. Stem Cells. 1998, 16: 166-177. 10.1002\/stem.160166.","journal-title":"Stem Cells"},{"key":"2472_CR8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nri2017","volume":"7","author":"LD Shultz","year":"2007","unstructured":"Shultz LD, Ishikawa F, Greiner DL: Humanized mice in translational biomedical research. Nat Rev Immunol. 2007, 7: 118-130. 10.1038\/nri2017.","journal-title":"Nat Rev Immunol"},{"key":"2472_CR9","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/0092-8674(92)90030-G","volume":"68","author":"P Mombaerts","year":"1992","unstructured":"Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE: RAG-1-deficient mice have no mature B and T lymphocytes. Cell. 1992, 68: 869-877. 10.1016\/0092-8674(92)90030-G.","journal-title":"Cell"},{"key":"2472_CR10","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/0092-8674(92)90029-C","volume":"68","author":"Y Shinkai","year":"1992","unstructured":"Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM, et al: RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell. 1992, 68: 855-867. 10.1016\/0092-8674(92)90029-C.","journal-title":"Cell"},{"key":"2472_CR11","doi-asserted-by":"publisher","first-page":"9305","DOI":"10.1073\/pnas.1004492107","volume":"107","author":"H Suwanai","year":"2010","unstructured":"Suwanai H, Wilcox MA, Mathis D, Benoist C: A defective Il15 allele underlies the deficiency in natural killer cell activity in nonobese diabetic mice. Proc Natl Acad Sci USA. 2010, 107: 9305-9310. 10.1073\/pnas.1004492107.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2472_CR12","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1073\/pnas.89.8.3290","volume":"89","author":"M Prochazka","year":"1992","unstructured":"Prochazka M, Gaskins HR, Shultz LD, Leiter EH: The NOD-scid mouse: a model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci USA. 1992, 89: 3290-3294. 10.1073\/pnas.89.8.3290.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2472_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev.immunol.14.1.179","volume":"14","author":"K Sugamura","year":"1996","unstructured":"Sugamura K, Asao H, Kondo M, Tanaka N, Ishii N, Ohbo K, Nakamura M, Takeshita T: The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu Rev Immunol. 1996, 14: 179-205. 10.1146\/annurev.immunol.14.1.179.","journal-title":"Annu Rev Immunol"},{"key":"2472_CR14","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1182\/blood.V87.3.956.bloodjournal873956","volume":"87","author":"K Ohbo","year":"1996","unstructured":"Ohbo K, Suda T, Hashiyama M, Mantani A, Ikebe M, Miyakawa K, Moriyama M, Nakamura M, Katsuki M, Takahashi K, et al: Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor gamma chain. Blood. 1996, 87: 956-967.","journal-title":"Blood"},{"key":"2472_CR15","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1093\/hmg\/4.9.1693","volume":"4","author":"C Tassara","year":"1995","unstructured":"Tassara C, Pepper AE, Puck JM: Intronic point mutation in the IL2RG gene causing X-linked severe combined immunodeficiency. Hum Mol Genet. 1995, 4: 1693-1695. 10.1093\/hmg\/4.9.1693.","journal-title":"Hum Mol Genet"},{"key":"2472_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1073\/pnas.92.2.377","volume":"92","author":"JP DiSanto","year":"1995","unstructured":"DiSanto JP, M\u00fcller W, Guy-Grand D, Fischer A, Rajewsky K: Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci USA. 1995, 92: 377-381. 10.1073\/pnas.92.2.377.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2472_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.1093933","volume":"304","author":"E Traggiai","year":"2004","unstructured":"Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, Lanzavecchia A, Manz MG: Development of a human adaptive immune system in cord blood cell-transplanted mice. Science. 2004, 304: 104-107. 10.1126\/science.1093933.","journal-title":"Science"},{"key":"2472_CR18","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","volume":"100","author":"M Ito","year":"2002","unstructured":"Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, Ueyama Y, Koyanagi Y, Sugamura K, Tsuji K, et al: NOD\/SCID\/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002, 100: 3175-3182. 10.1182\/blood-2001-12-0207.","journal-title":"Blood"},{"key":"2472_CR19","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1182\/blood.V95.10.3102","volume":"95","author":"O Kollet","year":"2000","unstructured":"Kollet O, Peled A, Byk T, Ben-Hur H, Greiner D, Shultz L, Lapidot T: Beta2 microglobulin-deficient (B2 m(null)) NOD\/SCID mice are excellent recipients for studying human stem cell function. Blood. 2000, 95: 3102-3105.","journal-title":"Blood"},{"key":"2472_CR20","first-page":"15","volume":"2","author":"PA Lowry","year":"1996","unstructured":"Lowry PA, Shultz LD, Greiner DL, Hesselton RM, Kittler EL, Tiarks CY, Rao SS, Reilly J, Leif JH, Ramshaw H, et al: Improved engraftment of human cord blood stem cells in NOD\/LtSz-scid\/scid mice after irradiation or multiple-day injections into unirradiated recipients. Biol Blood Marrow Transplant. 1996, 2: 15-23.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2472_CR21","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/j.1365-2249.2008.03753.x","volume":"154","author":"T Pearson","year":"2008","unstructured":"Pearson T, Shultz LD, Miller D, King M, Laning J, Fodor W, Cuthbert A, Burzenski L, Gott B, Lyons B, et al: Non-obese diabetic-recombination activating gene-1 (NOD-Rag 1(null)) interleukin (IL)-2 receptor common gamma chain (IL 2 rgamma(null)) null mice: a radioresistant model for human lymphohaematopoietic engraftment. Clin Exp Immunol. 2008, 154: 270-284. 10.1111\/j.1365-2249.2008.03753.x.","journal-title":"Clin Exp Immunol"},{"key":"2472_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.clim.2009.12.008","volume":"135","author":"MA Brehm","year":"2010","unstructured":"Brehm MA, Cuthbert A, Yang C, Miller DM, DiIorio P, Laning J, Burzenski L, Gott B, Foreman O, Kavirayani A, et al: Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation. Clin Immunol. 2010, 135: 84-98. 10.1016\/j.clim.2009.12.008.","journal-title":"Clin Immunol"},{"key":"2472_CR23","doi-asserted-by":"publisher","first-page":"e20169","DOI":"10.1371\/journal.pone.0020169","volume":"6","author":"R Akkina","year":"2011","unstructured":"Akkina R, Berges BK, Palmer BE, Remling L, Neff CP, Kuruvilla J, Connick E, Folkvord J, Gagliardi K, Kassu A, Akkina SR: Humanized Rag1-\/-gamma-chain-\/- mice support multilineage hematopoiesis and are susceptible to HIV-1 infection via systemic and vaginal routes. PLos ONE. 2011, 6: e20169-10.1371\/journal.pone.0020169.","journal-title":"PLos ONE"},{"key":"2472_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-3-540-75647-7_8","volume":"324","author":"S Baenziger","year":"2008","unstructured":"Baenziger S, Ziegler P, Mazzucchelli L, Bronz L, Speck RF, Manz MG: Human T cell development and HIV infection in human hemato-lymphoid system mice. Curr Top Microbiol Immunol. 2008, 324: 125-131. 10.1007\/978-3-540-75647-7_8.","journal-title":"Curr Top Microbiol Immunol"},{"key":"2472_CR25","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1182\/blood-2009-10-246959","volume":"115","author":"P Banerjee","year":"2010","unstructured":"Banerjee P, Tripp A, Lairmore MD, Crawford L, Sieburg M, Ramos J, Harrington WJ, Beilke MA, Feuer G: Adult T cell leukemia\/lymphoma development in HTLV-1-infected humanized SCID mice. Blood. 2010, 115: 2640-2648. 10.1182\/blood-2009-10-246959.","journal-title":"Blood"},{"key":"2472_CR26","doi-asserted-by":"publisher","first-page":"13891","DOI":"10.1128\/JVI.78.24.13891-13900.2004","volume":"78","author":"M Islas-Ohlmayer","year":"2004","unstructured":"Islas-Ohlmayer M, Padgett-Thomas A, Domiati-Saad R, Melkus MW, Cravens PD, Martin Mdel P, Netto G, Garcia JV: Experimental infection of NOD\/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virus. J Virol. 2004, 78: 13891-13900. 10.1128\/JVI.78.24.13891-13900.2004.","journal-title":"J Virol"},{"key":"2472_CR27","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1086\/590502","volume":"198","author":"M Yajima","year":"2008","unstructured":"Yajima M, Imadome K, Nakagawa A, Watanabe S, Terashima K, Nakamura H, Ito M, Shimizu N, Honda M, Yamamoto N, Fujiwara S: A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. J Inf Dis. 2008, 198: 673-682. 10.1086\/590502.","journal-title":"J Inf Dis"},{"key":"2472_CR28","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1086\/644644","volume":"200","author":"M Yajima","year":"2009","unstructured":"Yajima M, Imadome KI, Nakagawa A, Watanabe S, Terashima K, Nakamura H, Ito M, Shimizu N, Yamamoto N, Fujiwara S: T Cell-Mediated Control of Epstein-Barr Virus Infection in Humanized Mice. J Inf Dis. 2009, 200: 1611-1615. 10.1086\/644644.","journal-title":"J Inf Dis"},{"key":"2472_CR29","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1084\/jem.20081720","volume":"206","author":"T Strowig","year":"2009","unstructured":"Strowig T, Gurer C, Ploss A, Liu YF, Arrey F, Sashihara J, Koo G, Rice CM, Young JW, Chadburn A, et al: Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J Exp Med. 2009, 206: 1423-1434. 10.1084\/jem.20081720.","journal-title":"J Exp Med"},{"key":"2472_CR30","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/nm1431","volume":"12","author":"MW Melkus","year":"2006","unstructured":"Melkus MW, Estes JD, Padgett-Thomas A, Gatlin J, Denton PW, Othieno FA, Wege AK, Haase AT, Garcia JV: Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med. 2006, 12: 1316-1322. 10.1038\/nm1431.","journal-title":"Nat Med"},{"key":"2472_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1182\/blood-2005-04-1697","volume":"108","author":"W Wu","year":"2006","unstructured":"Wu W, Vieira J, Fiore N, Banerjee P, Sieburg M, Rochford R, Harrington WJ, Feuer G: KSHV\/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo. Blood. 2006, 108: 141-151. 10.1182\/blood-2005-04-1697.","journal-title":"Blood"},{"key":"2472_CR32","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1172\/JCI27249","volume":"116","author":"CH Parsons","year":"2006","unstructured":"Parsons CH, Adang LA, Overdevest J, O'Connor CM, Taylor JRJ, Camerini D, Kedes DH: KSHV targets multiple leukocyte lineages during long-term productive infection in NOD\/SCID mice. J Clin Invest. 2006, 116: 1963-1973. 10.1172\/JCI27249.","journal-title":"J Clin Invest"},{"key":"2472_CR33","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.chom.2010.08.001","volume":"8","author":"MS Smith","year":"2010","unstructured":"Smith MS, Goldman DC, Bailey AS, Pfaffle DL, Kreklywich CN, Spencer DB, Othieno FA, Streblow DN, Garcia JV, Fleming WH, Nelson JA: Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model. Cell Host Microbe. 2010, 8: 284-291. 10.1016\/j.chom.2010.08.001.","journal-title":"Cell Host Microbe"},{"key":"2472_CR34","doi-asserted-by":"publisher","first-page":"10664","DOI":"10.1128\/JVI.02584-08","volume":"83","author":"A Kwant-Mitchell","year":"2009","unstructured":"Kwant-Mitchell A, Ashkar AA, Rosenthal KL: Mucosal innate and adaptive immune responses against HSV-2 in a humanized mouse model. J Virol. 2009, 83: 10664-10676. 10.1128\/JVI.02584-08.","journal-title":"J Virol"},{"key":"2472_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.virol.2007.06.005","volume":"369","author":"JG Kuruvilla","year":"2007","unstructured":"Kuruvilla JG, Troyer RM, Devi S, Akkina R: Dengue virus infection and immune response in humanized Rag2-\/-\u03b3c-\/- (RAG-hu) mice. Virol. 2007, 369: 143-152. 10.1016\/j.virol.2007.06.005.","journal-title":"Virol"},{"key":"2472_CR36","doi-asserted-by":"publisher","first-page":"13797","DOI":"10.1128\/JVI.79.21.13797-13799.2005","volume":"79","author":"DA Bente","year":"2005","unstructured":"Bente DA, Melkus MW, Garcia JV, Rico-Hesse R: Dengue fever in humanized NOD\/SCID mice. J Virol. 2005, 79: 13797-13799. 10.1128\/JVI.79.21.13797-13799.2005.","journal-title":"J Virol"},{"key":"2472_CR37","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1002\/eji.200939480","volume":"39","author":"G Marodon","year":"2009","unstructured":"Marodon G, Desjardins D, Mercey L, Baillou C, Parent P, Manuel M, Caux C, Bellier B, Pasqual N, Klatzmann D: High diversity of the immune repertoire in humanized NOD.SCID.gammac(-\/-) mice. Eur J Immunol. 2009, 39: 2136-2145. 10.1002\/eji.200939480.","journal-title":"Eur J Immunol"},{"key":"2472_CR38","doi-asserted-by":"publisher","first-page":"20507","DOI":"10.1073\/pnas.0710528105","volume":"104","author":"KD Bissig","year":"2007","unstructured":"Bissig KD, Le TT, Woods NB, Verma IM: Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model. Proc Natl Acad Sci USA. 2007, 104: 20507-20511. 10.1073\/pnas.0710528105.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2472_CR39","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nbt1326","volume":"8","author":"H Azuma","year":"2007","unstructured":"Azuma H, Paulk N, Ranade A, Dorrell C, Al-Dhalimy M, Ellis E, Strom S, Kay MA, Finegold M, Grompe M: Robust expansion of human hepatocytes in Fah(-\/-)\/Rag2(-\/-)\/Il2rg(-\/-) mice. Nat Biotechnol. 2007, 8: 903-910.","journal-title":"Nat Biotechnol"},{"key":"2472_CR40","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1172\/JCI40094","volume":"120","author":"KD Bissig","year":"2010","unstructured":"Bissig KD, Wieland SF, Tran P, Isogawa M, Le TT, Chisari FV, Verma IM: Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J Clin Invest. 2010, 120: 924-930. 10.1172\/JCI40094.","journal-title":"J Clin Invest"},{"key":"2472_CR41","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2011.01.001","volume":"140","author":"ML Washburn","year":"2011","unstructured":"Washburn ML, Bility MT, Zhang L, Kovalev GI, Buntzman A, Frelinger JA, Barry W, Ploss A, Rice CM, Su L: A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease. Gastroenterology. 2011, 140: 1334-1344. 10.1053\/j.gastro.2011.01.001.","journal-title":"Gastroenterology"},{"key":"2472_CR42","doi-asserted-by":"publisher","first-page":"7305","DOI":"10.1128\/JVI.02207-08","volume":"83","author":"DM Brainard","year":"2009","unstructured":"Brainard DM, Seung E, Frahm N, Cariappa A, Bailey CC, Hart WK, Shin HS, Brooks SF, Knight HL, Eichbaum Q, et al: Induction of robust cellular and humoral virus-specific adaptive immune responses in HIV-infected humanized BLT mice. J Virol. 2009, 83: 7305-7321. 10.1128\/JVI.02207-08.","journal-title":"J Virol"},{"key":"2472_CR43","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1182\/blood-2006-04-017681","volume":"109","author":"S Watanabe","year":"2007","unstructured":"Watanabe S, Terashima K, Ohta S, Horibata S, Yajima M, Shiozawa Y, Dewan MZ, Yu Z, Ito M, Morio T, et al: Hematopoietic stem cell-engrafted NOD\/SCID\/IL2R{gamma}null mice develop human lymphoid system and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood. 2007, 109: 212-218. 10.1182\/blood-2006-04-017681.","journal-title":"Blood"},{"key":"2472_CR44","doi-asserted-by":"publisher","first-page":"15951","DOI":"10.1073\/pnas.0604493103","volume":"103","author":"S Baenziger","year":"2006","unstructured":"Baenziger S, Tussiwand R, Schlaepfer E, Mazzucchelli L, Heikenwalder M, Kurrer MO, Behnke S, Frey J, Oxenius A, Joller H, et al: Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-\/-{gamma}c-\/- mice. Proc Natl Acad Sci USA. 2006, 103: 15951-15956. 10.1073\/pnas.0604493103.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2472_CR45","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1084\/jem.20062411","volume":"204","author":"Z Sun","year":"2007","unstructured":"Sun Z, Denton PW, Estes JD, Othieno FA, Wei BL, Wege AK, Melkus MW, Padgett-Thomas A, Zupancic M, Haase AT, Garcia JV: Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1. J Exp Med. 2007, 204: 705-714. 10.1084\/jem.20062411.","journal-title":"J Exp Med"},{"key":"2472_CR46","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1128\/JVI.02010-06","volume":"81","author":"S Gorantla","year":"2007","unstructured":"Gorantla S, Sneller H, Walters L, Sharp JG, Pirruccello SJ, West JT, Wood C, Dewhurst S, Gendelman HE, Poluektova L: Human Immunodeficiency Virus Type 1 pathobiology studied in humanized Balb\/c-Rag2-\/-{gamma}c-\/- mice. J Virol. 2007, 81: 2700-2712. 10.1128\/JVI.02010-06.","journal-title":"J Virol"},{"key":"2472_CR47","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1182\/blood-2007-11-121319","volume":"111","author":"N Tonomura","year":"2008","unstructured":"Tonomura N, Habiro K, Shimizu A, Sykes M, Yang YG: Antigen-specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model. Blood. 2008, 111: 4293-4296. 10.1182\/blood-2007-11-121319.","journal-title":"Blood"},{"key":"2472_CR48","doi-asserted-by":"publisher","first-page":"12145","DOI":"10.1128\/JVI.01105-08","volume":"82","author":"U Hofer","year":"2008","unstructured":"Hofer U, Baenziger S, Heikenwalder M, Schlaepfer E, Gehre N, Regenass S, Brunner T, Speck RF: RAG2-\/-{gamma}c-\/- mice transplanted with human cord blood CD34+ cells show low intestinal engraftment and are resistant to rectal HIV transmission. J Virol. 2008, 82: 12145-12153. 10.1128\/JVI.01105-08.","journal-title":"J Virol"},{"key":"2472_CR49","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1182\/blood-2006-07-033159","volume":"109","author":"L Zhang","year":"2006","unstructured":"Zhang L, Kovalev GI, Su L: HIV-1 infection and pathogenesis in a novel humanized mouse model. Blood. 2006, 109: 2978-2981.","journal-title":"Blood"},{"key":"2472_CR50","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.virol.2008.02.036","volume":"376","author":"R Van Duyne","year":"2008","unstructured":"Van Duyne R, Cardenas J, Easley R, Wu W, Kehn-Hall K, Klase Z, Mendez S, Zeng C, Chen H, Saifuddin M, Kashanchi F: Effect of transcription peptide inhibitors on HIV-1 replication. Virol. 2008, 376: 308-322. 10.1016\/j.virol.2008.02.036.","journal-title":"Virol"},{"key":"2472_CR51","doi-asserted-by":"publisher","first-page":"e1000867","DOI":"10.1371\/journal.ppat.1000867","volume":"6","author":"U Hofer","year":"2010","unstructured":"Hofer U, Schlaepfer E, Baenziger S, Nischang M, Regenass S, Schwendener R, Kempf W, Nadal D, Speck RF: Inadequate clearance of translocated bacterial products in HIV-infected humanized mice. PLoS Pathog. 2010, 6: e1000867-10.1371\/journal.ppat.1000867.","journal-title":"PLoS Pathog"},{"key":"2472_CR52","doi-asserted-by":"publisher","first-page":"e12009","DOI":"10.1371\/journal.pone.0012009","volume":"5","author":"RM O'Connell","year":"2010","unstructured":"O'Connell RM, Balazs AB, Rao DS, Kivork C, Yang L, Baltimore D: Lentiviral Vector Delivery of Human Interleukin-7 (hIL-7) to Human Immune System (HIS) Mice Expands T Lymphocyte Populations. PLoS One. 2010, 5: e12009-10.1371\/journal.pone.0012009.","journal-title":"PLoS One"},{"key":"2472_CR53","doi-asserted-by":"publisher","first-page":"e1001225","DOI":"10.1371\/journal.ppat.1001225","volume":"6","author":"XM Luo","year":"2010","unstructured":"Luo XM, Lei MY, Feidi RA, West AP, Balazs AB, Bjorkman PJ, Yang L, Baltimore D: Dimeric 2G12 as a Potent Protection against HIV-1. PLoS Pathog. 2010, 6: e1001225-10.1371\/journal.ppat.1001225.","journal-title":"PLoS Pathog"},{"key":"2472_CR54","first-page":"66ra66","volume":"3","author":"CP Neff","year":"2011","unstructured":"Neff CP, Zhou J, Remling L, Kuruvilla J, Zhang J, Li H, Smith DD, Swiderski P, Rossi JJ, Akkina R: An Aptamer-siRNA Chimera Suppresses HIV-1 Viral Loads and Protects from Helper CD4+ T Cell Decline in Humanized Mice. Sci Transl Med. 2011, 3: 66ra66-","journal-title":"Sci Transl Med"},{"key":"2472_CR55","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.virol.2007.11.020","volume":"373","author":"BK Berges","year":"2008","unstructured":"Berges BK, Akkina SR, Folkvord JM, Connick E, Akkina R: Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2-\/-gc-\/- (RAG-hu) mice. Virology. 2008, 373: 342-351. 10.1016\/j.virol.2007.11.020.","journal-title":"Virology"},{"key":"2472_CR56","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.virol.2009.10.034","volume":"397","author":"BK Berges","year":"2010","unstructured":"Berges BK, Akkina SR, Remling L, Akkina R: Humanized Rag2(-\/-)gammac(-\/-) (RAG-hu) mice can sustain long-term chronic HIV-1 infection lasting more than a year. Virol. 2010, 397: 100-103. 10.1016\/j.virol.2009.10.034.","journal-title":"Virol"},{"key":"2472_CR57","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1742-4690-3-76","volume":"3","author":"BK Berges","year":"2006","unstructured":"Berges BK, Wheat WH, Palmer BE, Connick E, Akkina R: HIV-1 infection and CD4 T cell depletion in the humanized Rag2-\/-gc-\/- (RAG-hu) mouse model. Retrovirology. 2006, 3: 76-10.1186\/1742-4690-3-76.","journal-title":"Retrovirology"},{"key":"2472_CR58","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1128\/CVI.00403-06","volume":"14","author":"DS An","year":"2007","unstructured":"An DS, Poon B, Fang RHT, Weijer K, Blom B, Spits H, Chen ISY, Uittenbogaart CH: The human immune system (HIS) Rag2-\/-\u03b3c-\/- mouse, a novel chimeric mouse model for HIV-1 infection. Clinical Vaccine Immunology. 2007, 14: 391-396. 10.1128\/CVI.00403-06.","journal-title":"Clinical Vaccine Immunology"},{"key":"2472_CR59","doi-asserted-by":"publisher","first-page":"8254","DOI":"10.1128\/JVI.00580-09","volume":"83","author":"SK Choudhary","year":"2009","unstructured":"Choudhary SK, Rezk NL, Ince WL, Cheema M, Zhang L, Su L, Swanstrom R, Kashuba AD, Margolis DM: Suppression of HIV-1 viremia with reverse transcriptase and integrase inhibitors, CD4+ T cell recovery, and viral rebound upon therapy interruption in a new model for HIV treatment in the humanized Rag2-\/- {gamma}c-\/- mice. J Virol. 2009, 83: 8254-8258. 10.1128\/JVI.00580-09.","journal-title":"J Virol"},{"key":"2472_CR60","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/gt.2008.124","volume":"16","author":"O Ter Brake","year":"2009","unstructured":"Ter Brake O, Legrand N, von Eije KJ, Centlivre M, Spits H, Weijer K, Blom B, Berkhout B: Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system Rag2-\/-gc-\/- mouse model. Gene Ther. 2009, 16: 148-153. 10.1038\/gt.2008.124.","journal-title":"Gene Ther"},{"key":"2472_CR61","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1182\/blood-2008-03-145946","volume":"112","author":"Q Jiang","year":"2008","unstructured":"Jiang Q, Zhang L, Wang R, Jeffrey J, Washburn ML, Brouwer D, Barbour S, Kovalev GI, Unutmaz D, Su L: FoxP3+CD4+ regulatory T cells play an important role in acute HIV-1 infection in humanized Rag2-\/-gammaC-\/- mice in vivo. Blood. 2008, 112: 2858-2868. 10.1182\/blood-2008-03-145946.","journal-title":"Blood"},{"key":"2472_CR62","doi-asserted-by":"publisher","first-page":"e15257","DOI":"10.1371\/journal.pone.0015257","volume":"5","author":"CP Neff","year":"2010","unstructured":"Neff CP, Ndolo T, Tandon A, Habu Y, Akkina R: Oral pre-exposure prophylaxis by antiretrovirals raltegravir and maraviroc protects against HIV-1 vaginal transmission in a humanized mouse model. PloS One. 2010, 5: e15257-10.1371\/journal.pone.0015257.","journal-title":"PloS One"},{"issue":"23","key":"2472_CR63","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.1182\/blood-2011-01-331173","volume":"117","author":"L Zhang","year":"2011","unstructured":"Zhang L, Jiang Q, Li G, Jeffrey J, Kovalev GI, Su L: Efficient infection and impairment of pDC in the bone marrow and peripheral lymphoid organs during early HIV-1 infection in humanized rag2-\/-{gamma}C-\/- mice in vivo. Blood. 2011, 117 (23): 6184-92. 10.1182\/blood-2011-01-331173. Epub 2011 Apr 19","journal-title":"Blood"},{"key":"2472_CR64","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1089\/aid.2009.0136","volume":"26","author":"K Sango","year":"2010","unstructured":"Sango K, Joseph A, Patel M, Osiecki K, Dutta M, Goldstein H: Highly Active Antiretroviral Therapy Potently Suppresses HIV Infection in Humanized Rag2(-\/-)gamma(c)(-\/-) Mice. AIDS Res Hum Retroviruses. 2010, 26: 735-746. 10.1089\/aid.2009.0136.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2472_CR65","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1128\/JVI.02180-09","volume":"84","author":"WL Ince","year":"2010","unstructured":"Ince WL, Zhang L, Jiang Q, Arrildt K, Su L, Swanstrom R: Evolution of the HIV-1 env Gene in the Rag2-\/-{gamma}C-\/- Humanized Mouse Model. J Virol. 2010, 84: 2740-2752. 10.1128\/JVI.02180-09.","journal-title":"J Virol"},{"key":"2472_CR66","doi-asserted-by":"crossref","first-page":"B32","DOI":"10.1016\/j.vaccine.2009.10.154","volume":"28S2","author":"K Sato","year":"2010","unstructured":"Sato K, Nie C, Misawa N, Tanaka Y, Ito M, Koyanagi Y: Dynamics of memory and na\u00efve CD8(+) T lymphocytes in humanized NOD\/SCID\/IL-2Rgamma(null) mice infected with CCR5-tropic HIV-1. Vaccine. 2010, 28S2: B32-B37.","journal-title":"Vaccine"},{"key":"2472_CR67","doi-asserted-by":"publisher","first-page":"13259","DOI":"10.1128\/JVI.01353-07","volume":"81","author":"S Watanabe","year":"2007","unstructured":"Watanabe S, Ohta S, Yajima M, Terashima K, Ito M, Mugishima H, Fujiwara S, Shimizu K, Honda M, Shimizu N, Yamamoto N: Humanized NOD\/SCID\/IL2R{gamma}null Mice Transplanted with Hematopoietic Stem Cells under non-Myeloablative Condition Show Prolonged Lifespans and Allow Detailed Analysis of HIV-1 Pathogenesis. J Virol. 2007, 81: 13259-13264. 10.1128\/JVI.01353-07.","journal-title":"J Virol"},{"key":"2472_CR68","doi-asserted-by":"publisher","first-page":"6645","DOI":"10.1128\/JVI.02339-09","volume":"84","author":"A Joseph","year":"2010","unstructured":"Joseph A, Zheng JH, Chen K, Dutta M, Chen C, Stiegler G, Kunert R, Follenzi A, Goldstein H: Inhibition of In Vivo HIV Infection In Humanized Mice By Gene Therapy of Human Hematopoietic Stem Cells with a Lentiviral Vector Encoding a Broadly Neutralizing Anti-HIV Antibody. J Virol. 2010, 84: 6645-6653. 10.1128\/JVI.02339-09.","journal-title":"J Virol"},{"key":"2472_CR69","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.cell.2008.06.034","volume":"134","author":"P Kumar","year":"2008","unstructured":"Kumar P, Ban HS, Kim SS, Wu H, Pearson T, Greiner DL, Laouar A, Yao J, Haridas V, Habiro K, et al: T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell. 2008, 134: 577-586. 10.1016\/j.cell.2008.06.034.","journal-title":"Cell"},{"key":"2472_CR70","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/mt.2009.316","volume":"18","author":"R Mukherjee","year":"2010","unstructured":"Mukherjee R, Plesa G, Sherrill-Mix S, Richardson MW, Riley JL, Bushman FD: HIV Sequence Variation Associated With env Antisense Adoptive T-cell Therapy in the hNSG Mouse Model. Mol Ther. 2010, 18: 803-811. 10.1038\/mt.2009.316.","journal-title":"Mol Ther"},{"key":"2472_CR71","doi-asserted-by":"publisher","first-page":"7082","DOI":"10.4049\/jimmunol.1000438","volume":"184","author":"S Gorantla","year":"2010","unstructured":"Gorantla S, Makarov E, Finke-Dwyer J, Gebhart CL, Domm W, Dewhurst S, Gendelman HE, Poluektova LY: CD8+ Cell Depletion Accelerates HIV-1 Immunopathology in Humanized Mice. J Immun. 2010, 184: 7082-7091. 10.4049\/jimmunol.1000438.","journal-title":"J Immun"},{"key":"2472_CR72","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.virol.2009.08.011","volume":"394","author":"C Nie","year":"2009","unstructured":"Nie C, Sato K, Misawa N, Kitayama H, Fujino H, Hiramatsu H, Heike T, Nakahata T, Tanaka Y, Ito M, Koyanagi Y: Selective infection of CD4(+) effector memory T lymphocytes leads to preferential depletion of memory T lymphocytes in R5 HIV-1-infected humanized NOD\/SCID\/IL-2Rgamma(null) mice. Virology. 2009, 394: 64-72. 10.1016\/j.virol.2009.08.011.","journal-title":"Virology"},{"issue":"18","key":"2472_CR73","doi-asserted-by":"publisher","first-page":"9546","DOI":"10.1128\/JVI.00823-10","volume":"84","author":"K Sato","year":"2010","unstructured":"Sato K, Izumi T, Misawa N, Kobayashi T, Yamashita Y, Ohmichi M, Ito M, Takaori-Kondo A, Koyanagi Y: Remarkable lethal G-to-A mutations in vif-proficient HIV-1 provirus by individual APOBEC3 proteins in humanized mice. J Virol. 2010, 84 (18): 9546-56. 10.1128\/JVI.00823-10. Epub 2010 Jul 7","journal-title":"J Virol"},{"key":"2472_CR74","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nbt.1663","volume":"28","author":"N Holt","year":"2010","unstructured":"Holt N, Wang J, Kim K, Friedman G, Wang X, Taupin V, Crooks GM, Kohn DB, Gregory PD, Holmes MC, Cannon PM: Human hematopoietic stem\/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol. 2010, 28: 839-847. 10.1038\/nbt.1663.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"2472_CR75","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.2353\/ajpath.2010.100536","volume":"177","author":"S Gorantla","year":"2010","unstructured":"Gorantla S, Makarov E, Finke-Dwyer J, Castanedo A, Holguin A, Gebhart CL, Gendelman HE, Poluektova L: Links between Progressive HIV-1 Infection of Humanized Mice and Viral Neuropathogenesis. Am J Pathol. 2010, 177 (6): 2938-49. 10.2353\/ajpath.2010.100536. Epub 2010 Nov 18","journal-title":"Am J Pathol"},{"key":"2472_CR76","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1523\/JNEUROSCI.5473-10.2011","volume":"31","author":"PK Dash","year":"2011","unstructured":"Dash PK, Gorantla S, Gendelman HE, Knibbe J, Casale GP, Makarov E, Epstein AA, Gelbard HA, Boska MD, Poluektova LY: Loss of Neuronal Integrity during Progressive HIV-1 Infection of Humanized Mice. J Neurosci. 2011, 31: 3148-3157. 10.1523\/JNEUROSCI.5473-10.2011.","journal-title":"J Neurosci"},{"key":"2472_CR77","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1371\/journal.pmed.0050016","volume":"5","author":"PW Denton","year":"2008","unstructured":"Denton PW, Estes JD, Sun Z, Othieno FA, Wei BL, Wege AK, Powell DA, Payne D, Haase AT, Garcia JV: Antiretroviral Pre-exposure Prophylaxis Prevents Vaginal Transmission of HIV-1 in Humanized BLT Mice. PLoS Med. 2008, 5: e16-10.1371\/journal.pmed.0050016.","journal-title":"PLoS Med"},{"key":"2472_CR78","doi-asserted-by":"publisher","first-page":"e8829","DOI":"10.1371\/journal.pone.0008829","volume":"5","author":"PW Denton","year":"2010","unstructured":"Denton PW, Krisko JF, Powell DA, Mathias M, Kwak YT, Martinez-Torres F, Zou W, Payne DA, Estes JD, Garcia JV: Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice. PLoS One. 2010, 5: e8829-10.1371\/journal.pone.0008829.","journal-title":"PLoS One"},{"key":"2472_CR79","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1182\/blood-2009-04-215855","volume":"115","author":"S Shimizu","year":"2010","unstructured":"Shimizu S, Hong P, Arumugam B, Pokomo L, Boyer J, Koizumi N, Kittipongdaja P, Chen A, Bristol G, Galic Z, et al: A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model. Blood. 2010, 115: 1534-1544. 10.1182\/blood-2009-04-215855.","journal-title":"Blood"},{"key":"2472_CR80","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1743-422X-8-34","volume":"8","author":"H Garg","year":"2011","unstructured":"Garg H, Joshi A, Ye C, Shankar P, Manjunath N: Single amino acid change in gp41 region of HIV-1 alters bystander apoptosis and CD4 decline in humanized mice. Virol J. 2011, 8: 34-10.1186\/1743-422X-8-34.","journal-title":"Virol J"},{"key":"2472_CR81","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/mt.2009.271","volume":"18","author":"SS Kim","year":"2010","unstructured":"Kim SS, Peer D, Kumar P, Subramanya S, Wu H, Asthana D, Habiro K, Yang YG, Manjunath N, Shimaoka M, Shankar P: RNAi-mediated CCR5 Silencing by LFA-1-targeted Nanoparticles Prevents HIV Infection in BLT Mice. Mol Ther. 2010, 18: 370-376. 10.1038\/mt.2009.271.","journal-title":"Mol Ther"},{"key":"2472_CR82","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1172\/JCI117560","volume":"94","author":"AB van't Wout","year":"1994","unstructured":"van't Wout AB, Kootstra NA, Mulder-Kampinga GA, Albrecht-van Lent N, Scherpbier HJ, Veenstra J, Boer K, Coutinho RA, Miedema F, Schuitemaker H: Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission. J Clin Invest. 1994, 94: 2060-2067. 10.1172\/JCI117560.","journal-title":"J Clin Invest"},{"key":"2472_CR83","doi-asserted-by":"publisher","first-page":"e20209","DOI":"10.1371\/journal.pone.0020209","volume":"6","author":"CP Neff","year":"2011","unstructured":"Neff CP, Kurisu T, Ndolo T, Fox K, Akkina R: A Topical Microbicide Gel Formulation of CCR5 Antagonist Maraviroc Prevents HIV-1 Vaginal Transmission in Humanized RAG-hu Mice. PLos One. 2011, 6: e20209-10.1371\/journal.pone.0020209.","journal-title":"PLos One"},{"issue":"1","key":"2472_CR84","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.clim.2011.04.002","volume":"140","author":"J Lang","year":"2011","unstructured":"Lang J, Weiss N, Freed BM, Torres RM, Pelanda R: Generation of hematopoietic humanized mice in the newborn BALB\/c-Rag2(null)Il2r\u03b3(null) mouse model: A multivariable optimization approach. Clin Immunol. 2011, 140 (1): 102-16. 10.1016\/j.clim.2011.04.002. Epub 2011 Apr 14","journal-title":"Clin Immunol"},{"key":"2472_CR85","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1128\/JVI.02484-07","volume":"82","author":"K Boonnak","year":"2008","unstructured":"Boonnak K, Slike BM, Burgess TH, Mason RM, Wu SJ, Sun P, Porter K, Rudiman IF, Yuwono D, Puthavathana P, Marovich MA: Role of dendritic cells in antibody-dependent enhancement of dengue virus infection. J Virol. 2008, 82: 3939-3951. 10.1128\/JVI.02484-07.","journal-title":"J Virol"},{"key":"2472_CR86","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1073\/pnas.94.5.1925","volume":"94","author":"CC Bleul","year":"1997","unstructured":"Bleul CC, Wu L, Hoxie JA, Springer TA, Mackay CR: The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA. 1997, 94: 1925-1930. 10.1073\/pnas.94.5.1925.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2472_CR87","doi-asserted-by":"publisher","first-page":"8776","DOI":"10.1128\/JVI.76.17.8776-8786.2002","volume":"76","author":"O Kutsch","year":"2002","unstructured":"Kutsch O, Benveniste EN, Shaw GM, Levy DN: Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency. J Virol. 2002, 76: 8776-8786. 10.1128\/JVI.76.17.8776-8786.2002.","journal-title":"J Virol"},{"key":"2472_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/QAD.0b013e3280117f7f","volume":"21","author":"M Centlivre","year":"2007","unstructured":"Centlivre M, Sala M, Wain-Hobson S, Berkhout B: In HIV-1 pathogenesis the die is cast during primary infection. AIDS. 2007, 21: 1-11. 10.1097\/QAD.0b013e3280117f7f.","journal-title":"AIDS"},{"key":"2472_CR89","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1084\/jem.20040874","volume":"200","author":"JM Brenchley","year":"2004","unstructured":"Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ, Nguyen PL, Khoruts A, Larson M, Haase AT, Douek DC: CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med. 2004, 200: 749-759. 10.1084\/jem.20040874.","journal-title":"J Exp Med"},{"key":"2472_CR90","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1084\/jem.20041196","volume":"200","author":"S Mehandru","year":"2004","unstructured":"Mehandru S, Poles MA, Tenner-Racz K, Horowitz A, Hurley A, Hogan C, Boden D, Racz P, Markowitz M: Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med. 2004, 200: 761-770. 10.1084\/jem.20041196.","journal-title":"J Exp Med"},{"key":"2472_CR91","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/nature03501","volume":"434","author":"JJ Mattapallil","year":"2005","unstructured":"Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M: Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature. 2005, 434: 1093-1097. 10.1038\/nature03501.","journal-title":"Nature"},{"key":"2472_CR92","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1084\/jem.20070567","volume":"204","author":"A Okoye","year":"2007","unstructured":"Okoye A, Meier-Schellersheim M, Brenchley JM, Hagen SI, Walker JM, Rohankhedkar M, Lum R, Edgar JB, Planer SL, Legasse A, et al: Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection. J Exp Med. 2007, 204: 2171-2185. 10.1084\/jem.20070567.","journal-title":"J Exp Med"},{"key":"2472_CR93","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ni1316","volume":"7","author":"JM Brenchley","year":"2006","unstructured":"Brenchley JM, Price DA, Douek DC: HIV disease: fallout from a mucosal catastrophe?. Nat Immunol. 2006, 7: 235-239.","journal-title":"Nat Immunol"},{"key":"2472_CR94","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","volume":"12","author":"JM Brenchley","year":"2006","unstructured":"Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, et al: Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006, 12: 1365-1371.","journal-title":"Nat Med"},{"key":"2472_CR95","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1126\/science.287.5453.602","volume":"287","author":"S Gartner","year":"2000","unstructured":"Gartner S: HIV infection and dementia. Science. 2000, 287: 602-604. 10.1126\/science.287.5453.602.","journal-title":"Science"},{"key":"2472_CR96","doi-asserted-by":"publisher","first-page":"e7251","DOI":"10.1371\/journal.pone.0007251","volume":"4","author":"S Jaiswal","year":"2009","unstructured":"Jaiswal S, Pearson T, Friberg H, Shultz LD, Greiner DL, Rothman AL, Mathew A: Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice. PLoS ONE. 2009, 4: e7251-10.1371\/journal.pone.0007251.","journal-title":"PLoS ONE"},{"key":"2472_CR97","doi-asserted-by":"publisher","first-page":"e13137","DOI":"10.1371\/journal.pone.0013137","volume":"5","author":"PD Becker","year":"2010","unstructured":"Becker PD, Legrand N, van Geelen CM, Noerder M, Huntington ND, Lim A, Yasuda E, Diehl SA, Scheeren FA, Ott M, et al: Generation of human antigen-specific monoclonal IgM antibodies using vaccinated \"human immune system\" mice. PLoS One. 2010, 5: e13137-10.1371\/journal.pone.0013137.","journal-title":"PLoS One"},{"key":"2472_CR98","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1128\/JVI.78.5.2187-2200.2004","volume":"78","author":"N Frahm","year":"2004","unstructured":"Frahm N, Korber BT, Adams CM, Szinger JJ, Draenert R, Addo MM, Feeney ME, Yusim K, Sango K, Brown NV, et al: Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J Virol. 2004, 78: 2187-2200. 10.1128\/JVI.78.5.2187-2200.2004.","journal-title":"J Virol"},{"key":"2472_CR99","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11904-009-0033-9","volume":"7","author":"DM Margolis","year":"2010","unstructured":"Margolis DM: Mechanisms of HIV latency: an emerging picture of complexity. Curr HIV\/AIDS Rep. 2010, 7: 37-43. 10.1007\/s11904-009-0033-9.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2472_CR100","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.1128\/JVI.00124-08","volume":"82","author":"BF Keele","year":"2008","unstructured":"Keele BF, Tazi L, Gartner S, Liu Y, Burgon TB, Estes JD, Thacker TC, Crandall KA, McArthur JC, Burton GF: Characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1. J Virol. 2008, 82: 5548-5561. 10.1128\/JVI.00124-08.","journal-title":"J Virol"},{"key":"2472_CR101","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.virol.2005.09.062","volume":"345","author":"E Agbottah","year":"2006","unstructured":"Agbottah E, Zhang N, Dadgar S, Pumfery A, Wade JD, Zeng C, Kashanchi F: Inhibition of HIV-1 virus replication using small soluble Tat peptides. Virol. 2006, 345: 373-389. 10.1016\/j.virol.2005.09.062.","journal-title":"Virol"},{"key":"2472_CR102","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant RM, Lama JR, Anderson PL, et al: Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010, 363: 2587-2599. 10.1056\/NEJMoa1011205.","journal-title":"N Engl J Med"},{"key":"2472_CR103","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1084\/jem.20082013","volume":"206","author":"ND Huntington","year":"2009","unstructured":"Huntington ND, Legrand N, Alves NL, Jaron B, Weijer K, Plet A, Corcuff E, Mortier E, Jacques Y, Spits H, Di Santo JP: IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med. 2009, 206: 25-34. 10.1084\/jem.20082013.","journal-title":"J Exp Med"},{"key":"2472_CR104","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.imbio.2010.04.008","volume":"216","author":"EA Pek","year":"2011","unstructured":"Pek EA, Chan T, Reid S, Ashkar AA: Characterization and IL-15 dependence of NK cells in humanized mice. Immunobiology. 2011, 216: 218-224. 10.1016\/j.imbio.2010.04.008.","journal-title":"Immunobiology"},{"key":"2472_CR105","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.ymthe.2005.01.020","volume":"11","author":"DS Strayer","year":"2005","unstructured":"Strayer DS, Akkina R, Bunnell BA, Dropulic B, Planelles V, Pomerantz RJ, Rossi JJ, Zaia JA: Current status of gene therapy strategies to treat HIV\/AIDS. Mol Ther. 2005, 11: 823-842. 10.1016\/j.ymthe.2005.01.020.","journal-title":"Mol Ther"},{"key":"2472_CR106","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-1-61779-037-9_4","volume":"721","author":"J Zhou","year":"2011","unstructured":"Zhou J, Rossi JJ: Progress in RNAi-based antiviral therapeutics. Methods Mol Biol. 2011, 721: 67-75. 10.1007\/978-1-61779-037-9_4.","journal-title":"Methods Mol Biol"},{"key":"2472_CR107","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1017\/S1462399409001343","volume":"12","author":"JS Albin","year":"2010","unstructured":"Albin JS, Harris RS: Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics. Expert Rev Mol Med. 2010, 12: e4-","journal-title":"Expert Rev Mol Med"},{"key":"2472_CR108","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.tim.2008.08.013","volume":"16","author":"H Huthoff","year":"2008","unstructured":"Huthoff H, Towers GJ: Restriction of retroviral replication by APOBEC3G\/F and TRIM5alpha. Trends Microbiol. 2008, 16: 612-619. 10.1016\/j.tim.2008.08.013.","journal-title":"Trends Microbiol"},{"key":"2472_CR109","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.virol.2010.12.039","volume":"411","author":"SG Kitchen","year":"2011","unstructured":"Kitchen SG, Shimizu S, An DS: Stem cell-based anti-HIV gene therapy. Virology. 2011, 411: 260-272. 10.1016\/j.virol.2010.12.039.","journal-title":"Virology"},{"key":"2472_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/156652308783688536","volume":"8","author":"T Yamamoto","year":"2008","unstructured":"Yamamoto T, Tsunetsugu-Yokota Y: Prospects for the therapeutic application of lentivirus-based gene therapy to HIV-1 infection. Curr Gene Ther. 2008, 8: 1-8. 10.2174\/156652308783688536.","journal-title":"Curr Gene Ther"},{"key":"2472_CR111","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1056\/NEJM200301163480314","volume":"348","author":"S Hacein-Bey-Abina","year":"2003","unstructured":"Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, McIntyre E, Radford I, Villeval JL, Fraser CC, Cavazzana-Calvo M, Fischer A: A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med. 2003, 348: 255-256. 10.1056\/NEJM200301163480314.","journal-title":"N Engl J Med"},{"key":"2472_CR112","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/nbt1367","volume":"25","author":"JJ Rossi","year":"2007","unstructured":"Rossi JJ, June CH, Kohn DB: Genetic therapies against HIV. Nat Biotechnol. 2007, 25: 1444-1454. 10.1038\/nbt1367.","journal-title":"Nat Biotechnol"},{"key":"2472_CR113","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nbt0810-807","volume":"28","author":"SG Deeks","year":"2010","unstructured":"Deeks SG, McCune JM: Can HIV be cured with stem cell therapy?. Nat Biotech. 2010, 28: 807-810. 10.1038\/nbt0810-807.","journal-title":"Nat Biotech"},{"key":"2472_CR114","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJMoa0802905","volume":"360","author":"G H\u00fctter","year":"2009","unstructured":"H\u00fctter G, Nowak D, Mossner M, Ganepola S, M\u00fcssig A, Allers K, Schneider T, Hofmann J, K\u00fccherer C, Blau O, et al: Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation. N Engl J Med. 2009, 360: 692-698. 10.1056\/NEJMoa0802905.","journal-title":"N Engl J Med"},{"key":"2472_CR115","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1073\/pnas.97.3.1269","volume":"97","author":"H Blaak","year":"2000","unstructured":"Blaak H, van't Wout AB, Brouwer M, Hooibrink B, Hovenkamp E, Schuitemaker H: In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline. Proc Natl Acad Sci USA. 2000, 97: 1269-1274. 10.1073\/pnas.97.3.1269.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2472_CR116","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1128\/JVI.63.5.2118-2125.1989","volume":"63","author":"M Tersmette","year":"1989","unstructured":"Tersmette M, Gruters RA, de Wolf F, de Goede RE, Lange JM, Schellekens PT, Goudsmit J, Huisman HG, Miedema F: Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J Virol. 1989, 63: 2118-2125.","journal-title":"J Virol"},{"key":"2472_CR117","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1128\/JVI.02660-07","volume":"82","author":"JF Salazar-Gonzalez","year":"2008","unstructured":"Salazar-Gonzalez JF, Bailes E, Pham KT, Salazar MG, Guffey MB, Keele BF, Derdeyn CA, Farmer P, Hunter E, Allen S, et al: Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J Virol. 2008, 82: 3952-3970. 10.1128\/JVI.02660-07.","journal-title":"J Virol"},{"key":"2472_CR118","doi-asserted-by":"crossref","first-page":"10489","DOI":"10.1128\/JVI.73.12.10489-10502.1999","volume":"73","author":"R Shankarappa","year":"1999","unstructured":"Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, Farzadegan H, Gupta P, Rinaldo CR, Learn GH, He X, et al: Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol. 1999, 73: 10489-10502.","journal-title":"J Virol"},{"key":"2472_CR119","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1128\/JVI.70.6.4184-4187.1996","volume":"70","author":"RJ Gulizia","year":"1996","unstructured":"Gulizia RJ, Levy JA, Mosier DE: The envelope gp120 gene of human immunodeficiency virus type 1 determines the rate of CD4-positive T-cell depletion in SCID mice engrafted with human peripheral blood leukocytes. J Virol. 1996, 70: 4184-4187.","journal-title":"J Virol"},{"key":"2472_CR120","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1128\/JVI.78.5.2601-2605.2004","volume":"78","author":"AT Das","year":"2004","unstructured":"Das AT, Brummelkamp TR, Westerhout EM, Vink M, Madiredjo M, Bernards R, Berkhout B: Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J Virol. 2004, 78: 2601-2605. 10.1128\/JVI.78.5.2601-2605.2004.","journal-title":"J Virol"},{"key":"2472_CR121","doi-asserted-by":"publisher","first-page":"7079","DOI":"10.1128\/JVI.78.13.7079-7088.2004","volume":"78","author":"X Lu","year":"2004","unstructured":"Lu X, Yu Q, Binder GK, Chen Z, Slepushkina T, Rossi J, Dropulic B: Antisense-mediated inhibition of human immunodeficiency virus (HIV) replication by use of an HIV type 1-based vector results in severely attenuated mutants incapable of developing resistance. J Virol. 2004, 78: 7079-7088. 10.1128\/JVI.78.13.7079-7088.2004.","journal-title":"J Virol"},{"key":"2472_CR122","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.2353\/ajpath.2008.071186","volume":"173","author":"M Cocco","year":"2008","unstructured":"Cocco M, Bellan C, Tussiwand R, Corti D, Traggiai E, Lazzi S, Mannucci S, Bronz L, Palummo N, Ginanneschi C, et al: CD34+ Cord Blood Cell-Transplanted Rag2-\/- {gamma}c-\/- Mice as a Model for Epstein-Barr Virus Infection. Am J Pathol. 2008, 173: 1369-1378. 10.2353\/ajpath.2008.071186.","journal-title":"Am J Pathol"},{"key":"2472_CR123","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1053\/jhep.2001.23314","volume":"33","author":"M Dandri","year":"2010","unstructured":"Dandri M, Burda MR, T\u00f6r\u00f6k E, Pollok JM, Iwanska A, Sommer G, Rogiers X, Rogler CE, Gupta S, Will H, et al: Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology. 2010, 33: 981-988.","journal-title":"Hepatology"},{"key":"2472_CR124","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.chom.2010.09.003","volume":"8","author":"J Song","year":"2010","unstructured":"Song J, Willinger T, Rongvaux A, Eynon EE, Stevens S, Manz MG, Flavell RA, Gal\u00e1n JE: A mouse model for the human pathogen Salmonella typhi. Cell Host Microbe. 2010, 8: 369-376. 10.1016\/j.chom.2010.09.003.","journal-title":"Cell Host Microbe"},{"key":"2472_CR125","doi-asserted-by":"publisher","first-page":"e12357","DOI":"10.1371\/journal.pone.0012357","volume":"5","author":"J Kimpel","year":"2010","unstructured":"Kimpel J, Braun SE, Qiu G, Wong FE, Conolle M, Schmitz JE, Brendel C, Humeau LM, Dropulic B, Rossi JJ, et al: Survival of the fittest: positive selection of CD4+ T cells expressing a membrane-bound fusion inhibitor following HIV-1 infection. PLoS One. 2010, 5: e12357-10.1371\/journal.pone.0012357.","journal-title":"PLoS One"},{"key":"2472_CR126","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1742-4690-6-76","volume":"6","author":"R Van Duyne","year":"2009","unstructured":"Van Duyne R, Pedati C, Guendel I, Carpio L, Kehn-Hall K, Saifuddin M, Kashanchi F: The utilization of humanized mouse models for the study of human retroviral infections. Retrovirology. 2009, 6: 76-10.1186\/1742-4690-6-76.","journal-title":"Retrovirology"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4690-8-65.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1742-4690-8-65\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4690-8-65.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T06:42:56Z","timestamp":1592808176000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/1742-4690-8-65"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,11]]},"references-count":126,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["2472"],"URL":"https:\/\/doi.org\/10.1186\/1742-4690-8-65","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,11]]},"article-number":"65"}}